Quantcast

Latest drug discovery Stories

2014-06-03 23:04:04

The key factors propelling the growth of molecular spectroscopy market are increased investments, funding, and grants by government bodies worldwide - http://www.marketsandmarkets.com/Market-Reports/molecular-spectroscopy-market-50034395.html. (PRWEB) June 03, 2014 The "Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application...

2014-06-03 23:01:42

Panel at DIA Annual Meeting to Explore Evidentiary Standards and Regulatory Hurdles Washington (PRWEB) June 03, 2014 A forum on “FDA Programs to Encourage Innovation: Maximizing the Opportunities and Confronting the Challenges of New Product Development” will take place on June 17 at 10:30 a.m. as part of the DIA 2014 50th Annual Meeting at the San Diego Convention Center. As FDA promotes its initiatives to add flexibility to the drug approval process, scholars scrutinize their...

2014-06-03 12:25:14

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cell-Based Assays: World Industry and Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/cell_based_assays_world_market_prospects.html Report DetailsCellular testing for pharma - new report showing technological trends and sales forecastsWhat's the future of technologies for screening cells? Now you get technological and commercial predictions there from 2014....

2014-06-03 08:27:57

LONDON, June 3, 2014 Reportbuyer.com has added a new market research report:Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to...

2014-06-02 08:29:30

DUBLIN, June 2, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that its Endo Pharmaceuticals subsidiary has completed the sale of its branded pharmaceutical drug discovery platform to AsanaBioSciences, LLC, an independent member of the Amneal Alliance of Companies. The deal includes an upfront payment as well as milestones on the achievement of certain development objectives. Endo initiated the exploration of strategic alternatives for the...

2014-05-30 23:16:54

Dr. Bhubaneswar (Bud) Mishra joins InSilico Medicine Inc, a Baltimore-based bioinformatics and drug discovery company specializing in cancer and aging research and personalized medicine in age-related diseases. Baltimore, MD (PRWEB) May 30, 2014 InSilico Medicine, Inc, engaged in cancer and aging research for drug discovery and developing personalized approaches to extending productive longevity is proud to announce the addition of Prof. Bud Mishra to its board of scientific advisors....

2014-05-30 23:06:45

Dr. Igor Fisch to Present Data on Using Genome Engineering and the Selexis SURE CHO-Mplus Libraries for Optimal Transgene Expression and Recombinant Protein Production Geneva, Switzerland (PRWEB) May 30, 2014 Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development announced today the Company’s CEO, Igor Fisch, Ph.D., will present “Genome Engineering and SURE CHO-Mplus Libraries™ for Optimal Transgene Expression...

2014-05-30 23:05:16

Patient-centered sessions to address challenges in recruitment and guidance for engagement Washington (PRWEB) May 30, 2014 Sessions at the DIA 2014 50th Annual Meeting will bring together patient advocates and those dedicated to finding much-needed therapies to discuss the role of patients in accelerating collaboration and challenges in recruitment in the medical products industry. The annual meeting will be held at the San Diego Convention Center from June 15 to 19. “Patient advocate...

2014-05-29 08:29:27

SYDNEY, May 29, 2014 /PRNewswire/ -- RNAi-based therapeutics company, Benitec Biopharma Limited (ASX: BLT) is pleased to announce that it has dosed the first patient in its 'first in man', Phase I/IIa clinical trial for TT-034, a ddRNAi-based therapeutic, designed to treat and potentially cure hepatitis C (HCV) with a single injection. Benitec Biopharma's CEO and Managing Director, Peter French said, "The commencement of this clinical trial of TT-034 represents a landmark in the Company's...

2014-05-29 04:22:16

LONDON and BOSTON, May 29, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that Malcolm Weir, Heptares' Chief Executive Officer and co-founder, will give a company presentation at the Jefferies 2014 Global Healthcare in New York City, NY, USA. The presentation will take place at 9:00am EDT on Monday 2 June. In addition, Heptares will give presentations at the following industry and scientific...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related